The history of Alzheimer's disease

Alzheimer's disease is a terrible problem that has been affecting those old in age for centuries. Most of the knowledge that we have about the affliction, we've learned within the past one hundred years. In this article, we'll give you a brief history of our knowledge of the disease, letting you know where our basic understandings of the disease came from and some of the advances that are being made today.

Alzheimer's disease was first discovered by a German doctor named Alois Alzheimer. The doctor discovered the disease when he was performing an autopsy on a woman who died of a mysterious, unknown form of mental illness. When Alzheimer studied the brain of the woman, he was shocked to find the presence of abnormal lumps of plaque and twisted fibers present in her brain that were unlike anything he'd ever seen before. These two odd parts of the woman's anatomy proved to be the basis for Alzheimer's disease, with the lumps becoming known as neuritic plaques and the fibers being called neurofibrillary tangles. To this day, the presence of these lumps and fibers are the way that doctors can confirm the presence of Alzheimer's disease. Unfortunately, these symptoms can only be seen via an autopsy performed after a patient's death.

One discovery that changed our knowledge of Alzheimer's disease is when Familial Alzheimer's disease was discovered. This subset of the disease occurs in approximately 10 percent of all patients with Alzheimer's, and it is a particularly aggressive form of the disease. It occurs early in almost every case, with most becoming afflicted with the disease before the age of 65. One of the most unfortunate aspects of Familial Alzheimer's disease is the fact that it can be passed down genetically from parent to child. If one parent has Familial Alzheimer's, the child's risk of getting the disease rests at an even 50-50. Familial Alzheimer's is the only type of the disease that can be traced to a genetic abnormality; late-onset Alzheimer's may appear randomly and without just cause.

1993 saw one of the first significant developments in fighting Alzheimer's disease. In this year, the Food and Drug Administration of the United States of America gave approval to the first drug designed to help Alzheimer's patients. Known as Cognex, the pill worked to increase the amount of acetylcholine in the brain, which is a neurotransmitter that can help to slow the mind-damaging aspects of the disease. Within the next few years, 3 more drugs came out in order to increase acetylcholine levels in Alzheimer's patients. In 1997, scientists discovered that the use of Vitamin E and a Parkinson's disease drug known as Eldepryl were shown to be effective in slowing the mental decline of Alzheimer's patients, offering another solution when it comes to slowing the disease. The latest advancement came in 2003 when the FDA approved a radically different drug that is known as Namenda. It is used in order to protect the brain cells of an Alzheimer's patient by blocking the amount of Glutamine that is present in the brain, which can damage the cells.

More and more research is being conducted when it comes to finding possible solutions for those with Alzheimer's, and hopefully, the advancements that are being made will continue to help those with this devastating disease.

Alzheimer's Disease on the Web

A Rich Cognitive Life "Squares the Curve" of Decline Leading to Dementia - Medscape

Reuters

A Rich Cognitive Life "Squares the Curve" of Decline Leading to Dementia
Medscape
The current study focused on a slightly different question, he said, "and that is, what happens to people who develop Alzheimer's disease despite having ...
Staying mentally active could delay Alzheimer's diseaseNECN
Alzheimer's Trade-Off for Mentally Active SeniorsU.S. News & World Report
For the intellectually active, Alzheimer's diagnosis begins a steep slideLos Angeles Times
PhysOrg.com -BusinessWeek -Santa Barbara Independent
all 191 news articles »

What's Going on With Alzheimer's Coverage in the Media? - Huffington Post (blog)

Tbo.com

What's Going on With Alzheimer's Coverage in the Media?
Huffington Post (blog)
I am referring to the Times article, "Years Later, No Magic Bullet Against Alzheimer's Disease," that Gina Kolata wrote on August 29. ...
USF Alzheimer's center rising above research shortcomingsTbo.com

all 3 news articles »

Addex drug-candidate effective in Alzheimer's disease model - MarketWatch (press release)

Addex drug-candidate effective in Alzheimer's disease model
MarketWatch (press release)
Allosteric modulation company Addex Pharmaceuticals Ltd (SWISS: ADXN) announced today that it has observed efficacy in a model of Alzheimer's disease using ...
Addex drug-candidate effective in Alzheimer's disease modelMarketWatch

all 16 news articles »

Cell Publishes on the Critical Role of Metals in Alzheimer's Disease - MarketWatch (press release)

Cell Publishes on the Critical Role of Metals in Alzheimer's Disease
MarketWatch (press release)
PBT2 has completed a Phase 2a clinical trial where it significantly increased the cognitive performance of patients with Alzheimer's Disease after only 12 ...

and more »

Cancer drug may be used to treat Alzheimer's disease - RetirementHomes.com

Globe and Mail

Cancer drug may be used to treat Alzheimer's disease
RetirementHomes.com
Researchers in the United States recently announced that a drug used to treat a certain type of cancer may be able to treat Alzheimer's disease. ...
Fisher Scientists Discover Protein that Fuels Alzheimer's Disease, Promising ...PR Newswire (press release)
Finding Suggests New Aim for Alzheimer's DrugsNew York Times
Study links metals imbalance with Alzheimer'sAustralian Life Scientist
msnbc.com -CNN (blog) -Behavioral Health Central (blog)
all 79 news articles »

Preventing Alzheimer's Disease: A Foolproof Method? - AOL Health (blog)

Preventing Alzheimer's Disease: A Foolproof Method?
AOL Health (blog)
Everybody wants to believe that we can prevent Alzheimer's disease with memory exercises or by swallowing ginkgo biloba capsules or by taking FDA-approved ...

Ann Varnum will chair Alzheimer's 'A Walk to Remember' - Dothan Eagle

Ann Varnum will chair Alzheimer's 'A Walk to Remember'
Dothan Eagle
She knows from personal experience how devastating Alzheimer's disease can be as her younger sister has been diagnosed with it. ...

Years Later, No Magic Bullet Against Alzheimer's Disease - New York Times

Years Later, No Magic Bullet Against Alzheimer's Disease
New York Times
On trial was the question “Can anything — running on a treadmill, eating more spinach, learning Arabic — prevent Alzheimer's disease or delay its ...

and more »

Link Between Diabetes, Alzheimer's Disease Strengthened - BusinessWeek

Telegraph.co.uk

Link Between Diabetes, Alzheimer's Disease Strengthened
BusinessWeek
In fact, "the risk of plaque-type Alzheimer's disease pathology increases in a linear relationship with diabetes-related factors," according to one study ...
Insulin resistance linked to brain malformations seen in Alzheimer'sLos Angeles Times
Diabetes mellitus (Type 2) linked to Alzheimer's diseaseFood Consumer
Finding the link between diabetes and Alzheimer's diseaseeMaxHealth
Medical News Today -Cyber Web News -dBTechno
all 131 news articles »

J.K. Rowling gives millions for MS research - Reuters

CBC.ca

J.K. Rowling gives millions for MS research
Reuters
The new center will also look into other degenerative conditions such as Alzheimer's disease, Parkinson's disease and Huntingdon's disease, which like MS ...
JK Rowling Donates ₤10 Million for New MS Research ClinicMedscape
Rowling gives £10m for MS researchThe Press Association
JK Rowling Donates Millions To Found Research ClinicLuxist (blog)
Seer Press -Herald Sun -Tonic
all 578 news articles »


Google News